Jubilant Ingrevia Ltd (JUBLINGREA) is currently trading at 700.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Jubilant Ingrevia Limited is a global player in Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates, serving diverse sectors like Pharmaceuticals, Agrochemicals, Nutrition, and Consumer products. The company reported an 8% year-over-year increase in EBITDA for Q2 FY26 and a substantial 18% rise in Profit After Tax, demonstrating its ability to enhance profitability amidst challenging market conditions. Steady volume growth was seen across its segments. In the Specialty Chemicals segment, the company is capitalizing on CDMO opportunities with 10+ new molecules added recently and advanced discussions for others. This segment's margins are robust, over 25%, due to strong client traction and cost strategies. The Nutrition and Health Solutions business faced pricing pressures but countered them through volume growth and its strategic pipeline of EU Choline advantages following anti-dumping duties. Despite competitive pricing pressures, growth opportunities are leveraged. Jubilant Ingrevia's global manufacturing capabilities across multiple sites in India, including recent expansions at its facilities, reinforce its broad product offerings. The new Multipurpose Plant (MPP) at Gajraula will support future growth in its core business areas.

Over the past 52 weeks, Jubilant Ingrevia Ltd has traded between a low of ₹556.55 and a high of ₹851.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Jubilant Ingrevia Ltd has a market capitalization of approximately 11,162.42. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Jubilant Ingrevia Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 38.76 and operates in the Chemicals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Jubilant Ingrevia Ltd (JUBLINGREA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 11,162.42 Cr, Jubilant Ingrevia Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Jubilant Ingrevia Ltd operates in the Chemicals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Jubilant Ingrevia Ltd is 38.76. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Jubilant Ingrevia Ltd pays dividends with a current dividend yield of 0.71%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Jubilant Ingrevia Ltd include sector-specific challenges in the Chemicals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.